Fennec Pharmaceuticals Inc.

Healthcare · Biotechnology · United States

Last price 10.24 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 359.09M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of oto...